Transparency in Clinical Trials and its Impact on the Intelligence Community SLA, Boston March 20, 2007 Mark R Little, PhD Vice President, Business Intelligence.
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015
